Description
- Reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
- To increase your success in Quitting
- For those who smoke their first cigarette more than 30 minutes after waking up
- WARNING: This product can expose you to chemicals which are known to the State of California to cause cancer, birth defects or other reproductive harm. For more information, go to
Product Specs
| Item Number | 523887.0 |
|---|---|
| Catalog Number | 00135019602 |
| UOM | BX |
| Level 1 Family Description | Rx |
| Level 2 Category Description | Rx-Otc And Topicals |
| Level 3 Group Description | Smoking Cessation |
| Level 4 Sub-Category Description | Smoking Cessation |
| Active Ingredients | Nicotine Polacrilex |
| Alternate Manufacturer Number | 2416758 |
| Application | Stop Smoking Aid |
| Brand | Nicoderm CQ |
| Buy American Act (BAA) Compliant | No |
| Country of Origin | Unknown |
| Dosage Form | Transdermal Patch |
| FSA Eligible - Buy UOM | Yes |
| FSA Eligible - Primary UOM | Yes |
| FSA Eligible - Sell UOM | Yes |
| Generic Drug Code | 03421 |
| Manufacturer | Glaxo Consumer Products |
| Manufacturer # | 00135019602 |
| McKesson # | 523887 |
| NDC Number | 00135019602 |
| Strength | 7 mg Strength |
| Trade Agreement Act (TAA) Compliant | No |
| UNSPSC Code | 51143218 |
| Volume | 14 per Box |